Skip to content

HUMA

Humacyte, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.39
−8.09%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
8.04x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.50x
Price / sales
51.64x
Price / cash flow
-1.13x

Enterprise value

Enterprise value
$95.8M
EV / sales
45.17x
EV / EBITDA
-1.21x
EV / EBIT
-0.86x
Market cap
$109.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026